Clinical Trial: Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643727) titled 'Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients' on June 01.

Brief Summary: The goal of this clinical trial is to evaluate the feasibility of WGA-800CW with dedicated imaging systems for detection of invisible esophageal dysplasia in patients with Barrett's esophagus.

The main questions it aims to answer are:

* What is the optimal dose of WGA-800CW that maximizes the tumor-to-background ratio and enables clear visualization of the tumor?

* Can fluorescence endoscopy with WGA-800CW in combination with qFME detect dysplastic esophageal lesions?

I...